Invivyd (IVVD) Accounts Payables (2020 - 2026)
Invivyd's (IVVD) quarterly Accounts Payables came in at $13.7 million in Q4 2025, up 31.55% YoY from $10.4 million in Q4 2024, and down 24.08% on a QoQ basis from $18.1 million in Q3 2025.
Invivyd (IVVD) Accounts Payables (2020 - 2026) Analysis & Trends
Invivyd (IVVD) has 6 years of Accounts Payables data on file, last reported at $13.7 million in Q4 2025.
- Quarterly Accounts Payables rose 31.55% year-over-year to $13.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.7 million (up 31.55% YoY) and the FY2025 annual result came in at $13.7 million, up 31.55% from the prior year.
- Accounts Payables retreated to $13.7 million in Q4 2025, from $18.1 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $18.7 million in Q1 2022 to a low of $1.2 million in Q1 2024.
- A 5-year average of $10.9 million and a median of $10.4 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables plunged 80.25% — and 2025, when it jumped 648.2%.
- Tracing IVVD's Accounts Payables over 5 years: stood at $5.8 million in 2021, then sank by 73.77% to $1.5 million in 2022, then soared by 424.26% to $8.0 million in 2023, then jumped by 31.37% to $10.4 million in 2024, then soared by 31.55% to $13.7 million in 2025.
- The last three Accounts Payables figures came in at $13.7 million (Q4 2025), $18.1 million (Q3 2025), and $18.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Invivyd | 212.23 Mn | 52.15 Mn | 13.01 Mn | 9.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.49 Mn |
| Dec 31, 2025 | 13.74 Mn |
| Sep 30, 2025 | 18.10 Mn |
| Jun 30, 2025 | 18.05 Mn |
| Mar 31, 2025 | 8.74 Mn |
| Dec 31, 2024 | 10.45 Mn |
| Sep 30, 2024 | 17.71 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 7.95 Mn |
| Sep 30, 2023 | 9.17 Mn |
| Jun 30, 2023 | 4.11 Mn |
| Mar 31, 2023 | 5.91 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 16.77 Mn |
| Jun 30, 2022 | 14.23 Mn |
| Mar 31, 2022 | 18.68 Mn |
| Dec 31, 2021 | 5.78 Mn |
| Sep 30, 2021 | 17.56 Mn |
| Jun 30, 2021 | 10.72 Mn |